Document is current
Any future updates will be listed below
-
Authors
Dannehl, Dominik
Dijkstra, Tjeerd Maarten Hein
von Au, Alexandra
Scholz, Anna Sophie
Volmer, Léa Louise
Hahn, Markus
Hawighorst-Knapstein, Sabine
Chaudhuri, Ariane
Taran, Florin-Andrei
Wallwiener, Markus
Bauer, Armin
Wallwiener, Diethelm
Brucker, Sara Yvonne
Wallwiener, Stephanie
Hartkopf, Andreas
Engler, Tobias
-
Funding
Funding for this research was provided by:
AOK Baden-Wuerttemberg
- License Information
-
More Information
Article History
Received: 28 May 2025
Accepted: 16 September 2025
First Online: 17 October 2025
Declarations
:
: Dominik Dannehl—Honoraria from Gilead, Novartis, DaiichiSankyo, Onkowissen.TV and AstraZeneca Lea. Volmer—Honoraria from Novartis. Tobias Engler—Honoraria from AstraZeneca, Eli Lilly, Daiichi Sankyo, Gilead, GSK, MDS, Novartis, Pierre Fabre, Pfizer, Roche, Stemline. Andreas Hartkopf—Honoraria from Roche, Novartis, Lilly, MSD, AstraZeneca, Agendia, Seagen, GSK, ExactScience, Riemser, Teva, Onkowissen.TV, Gilead, Menarini Stemline, Pfizer, Amgen, Pierre Fabre, Eisai, Daiichi Sankyo, Thieme, Veracyte, Springer. All remaining authors have no conflict of interest to declare.
